DNA Nanobots is a leader in the design and delivery of DNA nanoparticles tailored for targeted therapies.
DNA Nanobots has raised $3.5M in total funding. The most recent round was Seed. The last funding was announced in December 2025.
DNA Nanobots's investors include National Institute of General Medical Science.
DNA Nanobots is headquartered in Powell, United States.
DNA Nanobots is a leader in the design and delivery of DNA nanoparticles tailored for targeted therapies.
DNA Nanobots is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"DNA Nanobots — Funding & Investors." VCBacked, December 17, 2025, https://www.vcbacked.co/company/dna-nanobots. Accessed September 30, 2026.
VCBacked. (2025). DNA Nanobots — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/dna-nanobots
{{cite web |title=DNA Nanobots — Funding & Investors |url=https://www.vcbacked.co/company/dna-nanobots |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated